Immunohistochemistry Analysis in Inflammatory Bowel Disease—Should We Bring to Light Interleukin-10?

<b>Background/Objectives:</b> Inflammatory bowel diseases (IBDs) are chronic intestinal disorders with an unpredictable course. In parallel with the advent of new biologic therapies targeting specific interleukin pathways, end-point targets have become more stringent, aiming for mucosal...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Christopher Pavel, Mircea Mihai Diculescu, Madalina Ilie, Oana-Mihaela Plotogea, Vasile Sandru, Valentin Enache, Dan-Ionut Gheonea, Alexandra Jichitu, Alexandru Constantinescu, Robert-Emmanuel Serban, Cosmin Viorel Bogu, Horia-Dan Liscu, Alex-Emilian Stepan
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Subjects:	inflammatory bowel disease immunohistochemical parameters biologic treatment
Online Access:	https://www.mdpi.com/2227-9059/13/2/406